* Non Metastatic Castration Resistant Prostate Cancer (updated 2024-12-01) ~ youtor.org

Non Metastatic Castration Resistant Prostate Cancer (updated 2024-12-01)

FDA DISCO A new drug approval for nonmetastatic castrationresistant prostate cancer [upl. by Celestina]

FDA DISCO A new drug approval for nonmetastatic castrationresistant prostate cancer

Duration: 5:01
30 views | 8 months ago

Dr Scher on Predicting Sensitivity to Treatment for mCRPC [upl. by Haase]

Dr Scher on Predicting Sensitivity to Treatment for mCRPC

Duration: 1:32
155 views | 17 Nov 2016

FDA DISCO Burst Edition FDA approval of Lynparza olaparib with abiraterone and prednison [upl. by Burbank340]

FDA DISCO Burst Edition FDA approval of Lynparza olaparib with abiraterone and prednison

Duration: 3:31
64 views | 5 months ago

Dr Kyriakopoulos on Adding Cabazitaxel to AbirateronePrednisone in Patients With MCRPC [upl. by Delos]

Dr Kyriakopoulos on Adding Cabazitaxel to AbirateronePrednisone in Patients With MCRPC

Duration: 1:17
223 views | 3 Sep 2021

Advanced Prostate Cancer and PatientCentric Treatment [upl. by Didi530]

Advanced Prostate Cancer and PatientCentric Treatment

Duration: 2:17
304 views | 3 months ago

Metastatic CastrateResistant Prostate Cancer Options and Possible Sequences [upl. by Akelahs]

Metastatic CastrateResistant Prostate Cancer Options and Possible Sequences

Duration: 26:01
137 views | 10 months ago

Evaluating the role of SBRT in metastatic castrateresistant prostate cancer [upl. by Benedick]

Evaluating the role of SBRT in metastatic castrateresistant prostate cancer

Duration: 1:29
37 views | 1 month ago

Quantitative 68GaPSMA11 PET and Outcomes in Metastatic Castrationresistant Prostate Cancer fol [upl. by Lanna]

Quantitative 68GaPSMA11 PET and Outcomes in Metastatic Castrationresistant Prostate Cancer fol

Duration: 30:54
110 views | 5 months ago

Efficacy and Toxicity of 177LuPSMA617 for mCRPC in a RealWorld Setting [upl. by Tinya31]

Efficacy and Toxicity of 177LuPSMA617 for mCRPC in a RealWorld Setting

Duration: 5:45
5.9K views | 1 Dec 2023

Enzalutamide Approved for Prostate Cancer With Biochemical Recurrence Stephen Freedland MD [upl. by Johanna]

Enzalutamide Approved for Prostate Cancer With Biochemical Recurrence Stephen Freedland MD

Duration: 13:24
27 views | 23 Mar 2015

Considerations in Treatment Selection [upl. by Merlina659]

Considerations in Treatment Selection

Duration: 1:59
341 views | 7 Apr 2023

Provenge Immunotherapy for Prostate Cancer [upl. by Stevenson]

Provenge Immunotherapy for Prostate Cancer

Duration: 4:35
35 views | 1 month ago

UromigosLive24 Radioligands Part 4 PEACE3 Results from ESMO 2024 [upl. by Anne-Corinne909]

UromigosLive24 Radioligands Part 4 PEACE3 Results from ESMO 2024

Duration: 11:13
149 views | 6 months ago

Perspectives in mCRPC in 2024 [upl. by Guevara]

Perspectives in mCRPC in 2024

Duration: 2:05
439 views | 8 months ago

Who should get abiraterone in nonmetastatic prostate cancer [upl. by Melone]

Who should get abiraterone in nonmetastatic prostate cancer

Duration: 0:46
657 views | 22 Apr 2022

UROwebinar Management of nmCRPC Putting current evidence into practice [upl. by Cheney]

UROwebinar Management of nmCRPC Putting current evidence into practice

Duration: 51:05
95 views | 3 Sep 2021

ASCO Patient amp Partner Testimonial Bayer [upl. by Asena]

ASCO Patient amp Partner Testimonial Bayer

Duration: 2:20
23 views | 4 months ago

New Clinical Genetic Model Better Predicts Survival for Men with mCRPC ASCO 2024 [upl. by Idnor]

New Clinical Genetic Model Better Predicts Survival for Men with mCRPC ASCO 2024

Duration: 4:23
133 views | 2 months ago

Perspectives in mCRPC in 2024 [upl. by Eselrahc]

Perspectives in mCRPC in 2024

Duration: 16:53
146 views | 7 May 2018

Improvements in Detecting and Treating Metastatic CRPC [upl. by Etteve]

Improvements in Detecting and Treating Metastatic CRPC

Duration: 5:33
41 views | 7 months ago

Treating mCRPC with Lutetium177 and Radium223 Expert Insights [upl. by Levin]

Treating mCRPC with Lutetium177 and Radium223 Expert Insights

Duration: 7:30
197 views | 28 Oct 2016

Drug development for metastatic castrationresistant prostate cancer [upl. by Aerdnua]

Drug development for metastatic castrationresistant prostate cancer

Duration: 1:16
11.3K views | 17 Jul 2023

New FDA Approved PARP Inhibitor Talzenna Talazoparib amp Xtandi markscholzmd AlexScholz pcri [upl. by Aerahs780]

New FDA Approved PARP Inhibitor Talzenna Talazoparib amp Xtandi markscholzmd AlexScholz pcri

Duration: 14:39
96 views | 7 months ago

Should radioligand therapies be used in earlier settings in prostate cancer [upl. by Yzzik]

Should radioligand therapies be used in earlier settings in prostate cancer

Duration: 0:45
763 views | 22 Jun 2013

Treatment With SipuleucelT in Advanced Prostate Cancer [upl. by Launce]

Treatment With SipuleucelT in Advanced Prostate Cancer

Duration: 9:50
2.5K views | 17 May 2019

Progression of Metastatic Prostate Cancer Defined [upl. by Llered]

Progression of Metastatic Prostate Cancer Defined

Duration: 3:24
97 views | 5 months ago

Lutetium177–PSMA617 improves selfreported pain and HRQoL in taxanenaïve patients with PSMAp [upl. by Cohberg704]

Lutetium177–PSMA617 improves selfreported pain and HRQoL in taxanenaïve patients with PSMAp

Duration: 4:41
66 views | 5 months ago

ARV766 well tolerated and shows promising clinical activity in metastatic castrationresistant [upl. by Gustaf584]

ARV766 well tolerated and shows promising clinical activity in metastatic castrationresistant

Duration: 2:26
503 views | 13 Jul 2015

Treatment Approaches for Newly Diagnosed mCRPC [upl. by Edac]

Treatment Approaches for Newly Diagnosed mCRPC

Duration: 11:00
310 views | 3 Sep 2013

Dr Finkelstein Discusses the Safety Profile of Radium223

Duration: 4:29
|

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024